Search Results - Vicky Makker

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience by Maria Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N. Grisham, Carol Aghajanian, Karen Cadoo

    Published in Gynecologic Oncology Reports (2019-05-01)
    Get full text
    Article


  2. 2

    Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report by Syed S. Mahmood, Carol L. Chen, Natalie Shapnik, Udhay Krishnan, Harsimran S. Singh, Vicky Makker

    Published in Gynecologic Oncology Reports (2018-08-01)
    Get full text
    Article


  3. 3

    Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation by Madhuri Martin, Rachel N. Grisham, Gulisa Turashvili, Darragh F. Halpenny, Carol A. Aghajanian, Vicky Makker

    Published in Gynecologic Oncology Reports (2017-11-01)
    Get full text
    Article


  4. 4

    Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors by Madhuri Martin, Joshua K. Sabari, Gulisa Turashvili, Darragh F. Halpenny, Hira Rizvi, Natalie Shapnik, Vicky Makker

    Published in Gynecologic Oncology Reports (2018-05-01)
    Get full text
    Article


  5. 5

    Brain metastases in patients with low-grade endometrial carcinoma by Paulina Cybulska, Marina Stasenko, Raanan Alter, Vicky Makker, Karen A. Cadoo, Yukio Sonoda, Nadeem R. Abu-Rustum, Jennifer J. Mueller, Mario M. Leitao, Jr.

    Published in Gynecologic Oncology Reports (2018-11-01)
    Get full text
    Article


  6. 6

    Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab by Nicoletta Colombo, Domenica Lorusso, Bradley J. Monk, Brian Slomovitz, Kosei Hasegawa, Angélica Nogueira-Rodrigues, Melissa Zale, Chinyere E. Okpara, Gianmaria Barresi, Jodi McKenzie, Vicky Makker

    Get full text
    Article


  7. 7

    Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer by Nicolás Gómez-Banoy, Eduardo J. Ortiz, Caroline S. Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew M. Pagano, Andrew J. Plodkowski, William A. Zammarrelli, Jennifer J. Mueller, Carol Aghajanian, Britta Weigelt, Vicky Makker, Paul Cohen, Juan C. Osorio

    Published in The Journal of Clinical Investigation (2024-09-01)
    Get full text
    Article


  8. 8

    Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146 by Razvan Cristescu, Andrey Loboda, Robert Orlowski, Vicky Makker, Matthew H Taylor, Carol Aghajanian, Petar Jelinic, Lea Dutta, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing

    Published in Journal for ImmunoTherapy of Cancer (2024-01-01)
    Get full text
    Article


  9. 9

    Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovary by Mackenzie W. Sullivan, M. Herman Chui, Alexa N. Kanbergs, Hunter Green, Kaitlyn Gill, Pier Selenica, Achim A. Jungbluth, Kara C. Long, Yukio Sonoda, Jennifer J. Mueller, Christopher Tarney, Rachel N. Grisham, Vicky Makker, Nadeem R. Abu-Rustum, Britta Weigelt, Roisín E. O’Cearbhaill

    Published in Gynecologic Oncology Reports (2026-04-01)
    Get full text
    Article


  10. 10

    A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma by Elizabeth H. Stover, Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak, Russell R. Broaddus, Vicky Makker, Ronny Drapkin, Joyce F. Liu, Neil S. Horowitz, Funda Meric-Bernstam, Carol Aghajanian, Robert L. Coleman, Gordon B. Mills, Lewis C. Cantley, Ursula A. Matulonis, Shannon N. Westin, Panagiotis A. Konstantinopoulos

    Published in Gynecologic Oncology Reports (2022-04-01)
    Get full text
    Article


  11. 11

    Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma by Robert G Maki, Martina Bradic, Phillip Wong, William Tap, Vicky Makker, Sandra D’Angelo, Angela Green, Mrinal M Gounder, Evan Rosenbaum, Ciara M Kelly, Jason E Chan, Ping Chi, Mark A Dickson, Mary L Keohan, Sujana Movva, Viswatej Avutu, Martee L Hensley, Maria M Rubinstein, Ronak Shah, Kenneth Seier, Karmelina Charalambous, Seth M Cohen, Lauren B Banks, Sara Saunds, Jae-Mun Cho, Robert A Lefkowitz, Joseph Erinjeri, Li-Xuan Qin

    Published in Journal for ImmunoTherapy of Cancer (2025-06-01)
    Get full text
    Article


Search Tools: